Literature DB >> 19091620

Optimal use of FRAX.

Christian Roux, Thierry Thomas.   

Abstract

Mesh：

Year:  2008        PMID： 19091620     DOI： 10.1016/j.jbspin.2008.11.001

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Guidance for the adjustment of FRAX according to the dose of glucocorticoids.

Authors:  J A Kanis; H Johansson; A Oden; E V McCloskey
Journal:  Osteoporos Int       Date:  2011-01-13       Impact factor: 4.507

2.  Were you identified to be at high fracture risk by FRAX® before your osteoporotic fracture occurred?

Authors:  Xiao-feng Chen; Xiao-lin Li; Hui Zhang; Ge-jun Liu
Journal:  Clin Rheumatol       Date:  2014-02-28       Impact factor: 2.980

3.  What was your fracture risk evaluated by FRAX® the day before your osteoporotic fracture?

Authors:  Bérengère Aubry-Rozier; Delphine Stoll; Marc-Antoine Krieg; Olivier Lamy; Didier Hans
Journal:  Clin Rheumatol       Date:  2012-11-01       Impact factor: 2.980

4.  Feasibility of FRAX for Prediction of Osteoporotic Vertebral Fractures in Korea.

Authors:  Gwang-Young So; Kyung-Ho Park; Dea-Hyun Yoon; Ji-Hoon Ryu; Yong-Soo Choi
Journal:  Asian Spine J       Date:  2012-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.